Coverage
-
June 01, 2026
Affiliates of TPG Capital must face a lawsuit seeking to claw back $4.1 billion they made from the sale of a generic opioid manufacturer to Endo International PLC, whose trustee has alleged it did not receive reasonably equivalent value in the deal.
27 other articles on this case.
View all »